Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ashton & Parsons Teething Powders is a traditional herbal medicinal product used for the symptomatic relief of teething pain in infants, including sore and tender gums, flushed cheeks, and dribbling, based solely on long-standing traditional use. Each sachet contains powder impregnated with 0.002 ml tincture of **Matricaria recutita L.** (chamomile) flower as the active ingredient, extracted using 70% v/v ethanol, and also includes **lactose** as an excipient. Administered orally by placing the powder on the infant's tongue, it is suitable for babies from 3 months of age (not recommended under 3 months), with dosing of half a sachet twice daily for 3-6 month olds or one sachet twice daily for over 6 months, repeatable up to 6 doses in 24 hours if needed; symptoms persisting beyond 7 days require medical consultation. It carries warnings for potential allergic reactions in those sensitive to Asteraceae/Compositae family plants or lactose intolerant individuals, and is THR 16853/0076 registered in the UK.[1][2][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ashton & Parsons.